CJC-1295 No DAC 5mg + Ipamorelin 5mg research peptide 10mg blend supplied as a lyophilised powder vial. High-purity research material for laboratory research use only, with batch verification and COA access where available.
Format
Lyophilised powder
Total Content
10mg blend
Blend Ratio
5mg CJC-1295 No DAC + 5mg Ipamorelin
Storage
Store refrigerated 2–8°C
Product Overview
CJC-1295 No DAC and Ipamorelin is a synthetic peptide blend commonly discussed in laboratory research involving growth hormone-releasing hormone receptor signalling, ghrelin receptor pathway research, peptide-receptor interaction models, and GH/IGF-1 axis investigation.
CJC-1295 No DAC, also referred to as Modified GRF 1-29, is a modified analogue of growth hormone-releasing hormone used in research models examining short-acting GHRH receptor pathway activity. Ipamorelin is a synthetic pentapeptide investigated in relation to ghrelin receptor and growth hormone secretagogue receptor signalling.
Common Research Interest Areas
- GHRH receptor pathway research
- Ghrelin receptor / GHSR signalling studies
- GH/IGF-1 axis research models
- Peptide-receptor interaction research
- Endocrine signalling pathway investigation
- In vitro analytical peptide research
Product Specifications
-
Compound: CJC-1295 No DAC + Ipamorelin
-
Synonyms: Modified GRF 1-29 + Ipamorelin
-
Total Vial Content: 10mg
-
Composition: 5mg CJC-1295 No DAC + 5mg Ipamorelin
-
Appearance: White to off-white lyophilised powder
-
Format: Lyophilised research peptide blend
-
Purity: ≥99% HPLC verified
-
Intended Setting: Laboratory research use only
-
Storage: Store refrigerated at 2–8°C in a dry, dark place
Scientific Values
-
CJC-1295 No DAC Synonyms: Modified GRF (1-29), CJC-1295 No DAC, GHRH (1-29)-NH2
-
CJC-1295 No DAC Molecular Formula: C152H252N44O42
-
CJC-1295 No DAC Molecular Weight: 3367.9 g/mol
-
CJC-1295 No DAC Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
-
Ipamorelin Molecular Formula: C38H49N9O5
-
Ipamorelin Molecular Weight: 711.9 g/mol
-
Ipamorelin CAS Number: 170851-70-4
-
Ipamorelin Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2
Batch Verification & COA Access
Each vial is intended to support batch-level verification on arrival. Customers can use the printed batch information to review available COA documentation and batch-specific analysis where available.
Batch testing may include HPLC purity analysis, identity confirmation, and related analytical documentation depending on the current production batch.
COA documentation is updated regularly as new batch testing becomes available. On some occasions, a COA may not be immediately available for a newly received batch while documentation is being reviewed and uploaded. Please check our Lab Results / COA page for the latest available batch information.
Storage & Handling
Store lyophilised peptide vials refrigerated at 2–8°C in a dry, dark place. Keep sealed until required for laboratory research preparation. Avoid prolonged exposure to heat, moisture and direct light.
Handling should be carried out only by qualified individuals using suitable laboratory procedures and appropriate research handling standards.
Important Information
This product is supplied strictly for laboratory research and analytical purposes only.
Not for human or veterinary use. For research use only.
This product is not a medicine, food, cosmetic, supplement, diagnostic product or medical product.
We do not provide dosage, administration, injection, reconstitution volume, personal-use guidance or therapeutic advice, in line with our research-use-only policy.
Product images are for illustrative purposes only. Packaging, vial appearance, powder quantity, label design and batch presentation may vary between production batches. Please refer to current batch documentation for product-specific verification.
